JCR Pharmaceuticals Celebrates 50 Years of Innovation with Global Website Launch That Reflects Its Expanding Reach and Human-Centric Mission As JCR Pharmaceuticals commemorates its 50th anniversary, the global specialty biopharmaceutical…
WHO Advances Global Chemical Hazard Preparedness with New Comprehensive Online Training Series In a recent address to the Seventy-eighth World Health Assembly, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World…
Otsuka Unveils Promising Phase 3 Results for Sibeprenlimab in IgA Nephropathy, Marking Significant Proteinuria Reduction and Advancing a Novel APRIL-Targeted Therapy Otsuka Pharmaceutical Development & Commercialization, Inc., in collaboration with…
Vertex Showcases Robust Clinical Data Supporting ALYFTREK® and the Critical Role of Sweat Chloride Reduction at 2025 European Cystic Fibrosis Conference New findings reinforce the value of CFTR modulation and…
Sanofi Highlights Robust Pipeline of Innovations in Rare Blood Disorders at ISTH 2025 Sanofi is poised to take center stage at the 33rd Congress of the International Society on Thrombosis…
AstraZeneca’s Fixed-Duration Calquence Regimen Gains EU Approval for First-Line Treatment of Chronic Lymphocytic Leukaemia AstraZeneca has received European Union (EU) approval for a fixed-duration combination therapy using its Bruton’s tyrosine…
A Life-Course Approach to Immunization: Prioritizing Vaccination at Every Age to Unlock the Full Potential of Lifelong Health In a striking demographic milestone, the global population is undergoing a historic…
WHO Sounds Alarm on Imminent Collapse of Gaza Health System as Nasser and Al-Amal Hospitals Face Shutdown The World Health Organization (WHO) has issued an urgent warning about the imminent…
Anne-Catherine Berner Appointed as New Chair of Grifols: A Strategic Move Toward Long-Term Value Creation and Governance Excellence Grifols a global leader in the development of plasma-derived therapies and diagnostic…
Bayer’s CONFIDENCE Study Demonstrates Promising Results for Simultaneous Use of Finerenone and Empagliflozin in Managing Chronic Kidney Disease in Type 2 Diabetes Bayer has announced compelling new clinical findings from…
Zoetis Unveils 2024 Sustainability Progress Report, Showcasing Global Commitments to Communities, Animal Health, and the Planet Zoetis, a global leader in animal health, has released its 2024 Sustainability Progress Update,…
Sanofi Unveils 2025 Global Employee Shareholding Plan, Reinforcing Long-Term Workforce Commitment Sanofi has officially launched Action 2025, the latest installment of its long-running global employee shareholder program. Opening on June…